APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepcidin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Hepcidin Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchHepcidin Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepcidin Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Hepcidin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepcidin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepcidin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Hepcidin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hepcidin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hepcidin market include Protagonist Therapeutics Inc, Pieris Pharmaceuticals Inc, Noxxon Pharma AG and Daiichi Sankyo Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hepcidin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hepcidin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hepcidin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hepcidin market size, projected growth trends, production technologies, key applications, and end-use industries.

Hepcidin Segment by Company

Protagonist Therapeutics Inc

Pieris Pharmaceuticals Inc

Noxxon Pharma AG

Daiichi Sankyo Co Ltd

Hepcidin Segment by Type

PTG-300

PRS-080

M-009

DS-79182026

Others

Hepcidin Segment by Application

Acute Inflammation

Sickle Cell Disease

Anemia

Iron Deficiency Anemia

Others

Hepcidin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hepcidin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hepcidin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hepcidin significant trends, drivers, influence factors in global and regions.

6. To analyze Hepcidin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepcidin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepcidin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepcidin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hepcidin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hepcidin industry.

Chapter 3: Detailed analysis of Hepcidin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hepcidin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hepcidin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hepcidin Industry Trends Table 2. Hepcidin Industry Drivers Table 3. Hepcidin Industry Opportunities and Challenges Table 4. Hepcidin Industry Restraints Table 5. Global Hepcidin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hepcidin Revenue Share by Company (2021-2026) Table 7. Global Hepcidin Sales Volume by Company (k units) & (2021-2026) Table 8. Global Hepcidin Sales Volume Share by Company (2021-2026) Table 9. Global Hepcidin Average Price (US$/unit) of Company (2021-2026) Table 10. Global Hepcidin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hepcidin Key Company Manufacturing Base & Headquarters Table 12. Global Hepcidin Company, Product Type & Application Table 13. Global Hepcidin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hepcidin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PTG-300 Table 18. Significant Companies of PRS-080 Table 19. Significant Companies of M-009 Table 20. Significant Companies of DS-79182026 Table 21. Significant Companies of Others Table 22. Global Hepcidin Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Hepcidin Sales Volume by Type (2021-2026) & (k units) Table 24. Global Hepcidin Sales Volume by Type (2027-2032) & (k units) Table 25. Global Hepcidin Sales Volume Share by Type (2021-2026) Table 26. Global Hepcidin Sales Volume Share by Type (2027-2032) Table 27. Global Hepcidin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Hepcidin Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Hepcidin Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Hepcidin Sales Value Share by Type (2021-2026) Table 31. Global Hepcidin Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Acute Inflammation Table 33. Significant Companies of Sickle Cell Disease Table 34. Significant Companies of Anemia Table 35. Significant Companies of Iron Deficiency Anemia Table 36. Significant Companies of Others Table 37. Global Hepcidin Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Hepcidin Sales Volume by Application (2021-2026) & (k units) Table 39. Global Hepcidin Sales Volume by Application (2027-2032) & (k units) Table 40. Global Hepcidin Sales Volume Share by Application (2021-2026) Table 41. Global Hepcidin Sales Volume Share by Application (2027-2032) Table 42. Global Hepcidin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Hepcidin Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Hepcidin Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Hepcidin Sales Value Share by Application (2021-2026) Table 46. Global Hepcidin Sales Value Share by Application (2027-2032) Table 47. Global Hepcidin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Hepcidin Sales by Region (2021-2026) & (k units) Table 49. Global Hepcidin Sales Market Share by Region (2021-2026) Table 50. Global Hepcidin Sales by Region (2027-2032) & (k units) Table 51. Global Hepcidin Sales Market Share by Region (2027-2032) Table 52. Global Hepcidin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Hepcidin Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Hepcidin Sales Value Share by Region (2021-2026) Table 55. Global Hepcidin Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Hepcidin Sales Value Share by Region (2027-2032) Table 57. Global Hepcidin Market Average Price (US$/unit) by Region (2021-2026) Table 58. Global Hepcidin Market Average Price (US$/unit) by Region (2027-2032) Table 59. Global Hepcidin Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 60. Global Hepcidin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Hepcidin Sales by Country (2021-2026) & (k units) Table 62. Global Hepcidin Sales Market Share by Country (2021-2026) Table 63. Global Hepcidin Sales by Country (2027-2032) & (k units) Table 64. Global Hepcidin Sales Market Share by Country (2027-2032) Table 65. Global Hepcidin Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Hepcidin Sales Value Market Share by Country (2021-2026) Table 67. Global Hepcidin Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Hepcidin Sales Value Market Share by Country (2027-2032) Table 69. Protagonist Therapeutics Inc Company Information Table 70. Protagonist Therapeutics Inc Business Overview Table 71. Protagonist Therapeutics Inc Hepcidin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Protagonist Therapeutics Inc Hepcidin Product Portfolio Table 73. Protagonist Therapeutics Inc Recent Development Table 74. Pieris Pharmaceuticals Inc Company Information Table 75. Pieris Pharmaceuticals Inc Business Overview Table 76. Pieris Pharmaceuticals Inc Hepcidin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Pieris Pharmaceuticals Inc Hepcidin Product Portfolio Table 78. Pieris Pharmaceuticals Inc Recent Development Table 79. Noxxon Pharma AG Company Information Table 80. Noxxon Pharma AG Business Overview Table 81. Noxxon Pharma AG Hepcidin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Noxxon Pharma AG Hepcidin Product Portfolio Table 83. Noxxon Pharma AG Recent Development Table 84. Daiichi Sankyo Co Ltd Company Information Table 85. Daiichi Sankyo Co Ltd Business Overview Table 86. Daiichi Sankyo Co Ltd Hepcidin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Daiichi Sankyo Co Ltd Hepcidin Product Portfolio Table 88. Daiichi Sankyo Co Ltd Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Hepcidin Distributors List Table 92. Hepcidin Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Hepcidin Product Image Figure 2. Global Hepcidin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepcidin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hepcidin Sales (2021-2032) & (k units) Figure 5. Global Hepcidin Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Hepcidin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PTG-300 Image Figure 10. PRS-080 Image Figure 11. M-009 Image Figure 12. DS-79182026 Image Figure 13. Others Image Figure 14. Global Hepcidin Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Hepcidin Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Hepcidin Sales Volume Share by Type (2021-2032) Figure 17. Global Hepcidin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Hepcidin Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Hepcidin Sales Value Share by Type (2021-2032) Figure 20. Acute Inflammation Image Figure 21. Sickle Cell Disease Image Figure 22. Anemia Image Figure 23. Iron Deficiency Anemia Image Figure 24. Others Image Figure 25. Global Hepcidin Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Hepcidin Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Hepcidin Sales Volume Share by Application (2021-2032) Figure 28. Global Hepcidin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Hepcidin Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Hepcidin Sales Value Share by Application (2021-2032) Figure 31. Global Hepcidin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 32. Global Hepcidin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Hepcidin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Hepcidin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Hepcidin Sales Value (2021-2032) & (US$ Million) Figure 36. North America Hepcidin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Hepcidin Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Hepcidin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Hepcidin Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Hepcidin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Hepcidin Sales Value (2021-2032) & (US$ Million) Figure 42. South America Hepcidin Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Hepcidin Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Hepcidin Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Hepcidin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Hepcidin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Hepcidin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Hepcidin Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Hepcidin Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • PTG-300
  • PRS-080
  • M-009
  • DS-79182026
  • Others
Applications
  • Acute Inflammation
  • Sickle Cell Disease
  • Anemia
  • Iron Deficiency Anemia
  • Others
Companies covered
  • Protagonist Therapeutics Inc
  • Pieris Pharmaceuticals Inc
  • Noxxon Pharma AG
  • Daiichi Sankyo Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hepcidin Sales Value (2021-2032)
  4. 1.2.2 Global Hepcidin Sales Volume (2021-2032)
  5. 1.2.3 Global Hepcidin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hepcidin Market Dynamics
  1. 2.1 Hepcidin Industry Trends
  2. 2.2 Hepcidin Industry Drivers
  3. 2.3 Hepcidin Industry Opportunities and Challenges
  4. 2.4 Hepcidin Industry Restraints
3 Hepcidin Market by Company
  1. 3.1 Global Hepcidin Company Revenue Ranking in 2025
  2. 3.2 Global Hepcidin Revenue by Company (2021-2026)
  3. 3.3 Global Hepcidin Sales Volume by Company (2021-2026)
  4. 3.4 Global Hepcidin Average Price by Company (2021-2026)
  5. 3.5 Global Hepcidin Company Ranking (2024-2026)
  6. 3.6 Global Hepcidin Company Manufacturing Base and Headquarters
  7. 3.7 Global Hepcidin Company Product Type and Application
  8. 3.8 Global Hepcidin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hepcidin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hepcidin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hepcidin Market by Type
  1. 4.1 Hepcidin Type Introduction
  2. 4.1.1 PTG-300
  3. 4.1.2 PRS-080
  4. 4.1.3 M-009
  5. 4.1.4 DS-79182026
  6. 4.1.5 Others
  7. 4.2 Global Hepcidin Sales Volume by Type
  8. 4.2.1 Global Hepcidin Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Hepcidin Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Hepcidin Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Hepcidin Sales Value by Type
  12. 4.3.1 Global Hepcidin Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Hepcidin Sales Value by Type (2021-2032)
  14. 4.3.3 Global Hepcidin Sales Value Share by Type (2021-2032)
5 Hepcidin Market by Application
  1. 5.1 Hepcidin Application Introduction
  2. 5.1.1 Acute Inflammation
  3. 5.1.2 Sickle Cell Disease
  4. 5.1.3 Anemia
  5. 5.1.4 Iron Deficiency Anemia
  6. 5.1.5 Others
  7. 5.2 Global Hepcidin Sales Volume by Application
  8. 5.2.1 Global Hepcidin Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Hepcidin Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Hepcidin Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Hepcidin Sales Value by Application
  12. 5.3.1 Global Hepcidin Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Hepcidin Sales Value by Application (2021-2032)
  14. 5.3.3 Global Hepcidin Sales Value Share by Application (2021-2032)
6 Hepcidin Regional Sales and Value Analysis
  1. 6.1 Global Hepcidin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hepcidin Sales by Region (2021-2032)
  3. 6.2.1 Global Hepcidin Sales by Region: 2021-2026
  4. 6.2.2 Global Hepcidin Sales by Region (2027-2032)
  5. 6.3 Global Hepcidin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hepcidin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hepcidin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hepcidin Sales Value by Region (2027-2032)
  9. 6.5 Global Hepcidin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hepcidin Sales Value (2021-2032)
  12. 6.6.2 North America Hepcidin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hepcidin Sales Value (2021-2032)
  15. 6.7.2 Europe Hepcidin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hepcidin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hepcidin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hepcidin Sales Value (2021-2032)
  21. 6.9.2 South America Hepcidin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hepcidin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hepcidin Sales Value Share by Country, 2025 VS 2032
7 Hepcidin Country-level Sales and Value Analysis
  1. 7.1 Global Hepcidin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hepcidin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hepcidin Sales by Country (2021-2032)
  4. 7.3.1 Global Hepcidin Sales by Country (2021-2026)
  5. 7.3.2 Global Hepcidin Sales by Country (2027-2032)
  6. 7.4 Global Hepcidin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hepcidin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hepcidin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hepcidin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hepcidin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hepcidin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hepcidin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hepcidin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hepcidin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hepcidin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hepcidin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hepcidin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hepcidin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hepcidin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hepcidin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hepcidin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hepcidin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hepcidin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hepcidin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hepcidin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hepcidin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hepcidin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hepcidin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hepcidin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hepcidin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hepcidin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hepcidin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hepcidin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hepcidin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hepcidin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hepcidin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hepcidin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hepcidin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hepcidin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hepcidin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hepcidin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hepcidin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hepcidin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hepcidin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hepcidin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hepcidin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hepcidin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hepcidin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hepcidin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hepcidin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hepcidin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hepcidin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hepcidin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hepcidin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hepcidin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hepcidin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hepcidin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hepcidin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hepcidin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hepcidin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hepcidin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hepcidin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hepcidin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hepcidin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hepcidin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hepcidin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hepcidin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hepcidin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hepcidin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hepcidin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hepcidin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hepcidin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hepcidin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hepcidin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hepcidin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hepcidin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hepcidin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hepcidin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hepcidin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hepcidin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hepcidin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hepcidin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hepcidin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hepcidin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hepcidin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hepcidin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hepcidin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hepcidin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hepcidin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hepcidin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hepcidin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hepcidin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Protagonist Therapeutics Inc
  2. 8.1.1 Protagonist Therapeutics Inc Company Information
  3. 8.1.2 Protagonist Therapeutics Inc Business Overview
  4. 8.1.3 Protagonist Therapeutics Inc Hepcidin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Protagonist Therapeutics Inc Hepcidin Product Portfolio
  6. 8.1.5 Protagonist Therapeutics Inc Recent Developments
  7. 8.2 Pieris Pharmaceuticals Inc
  8. 8.2.1 Pieris Pharmaceuticals Inc Company Information
  9. 8.2.2 Pieris Pharmaceuticals Inc Business Overview
  10. 8.2.3 Pieris Pharmaceuticals Inc Hepcidin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pieris Pharmaceuticals Inc Hepcidin Product Portfolio
  12. 8.2.5 Pieris Pharmaceuticals Inc Recent Developments
  13. 8.3 Noxxon Pharma AG
  14. 8.3.1 Noxxon Pharma AG Company Information
  15. 8.3.2 Noxxon Pharma AG Business Overview
  16. 8.3.3 Noxxon Pharma AG Hepcidin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Noxxon Pharma AG Hepcidin Product Portfolio
  18. 8.3.5 Noxxon Pharma AG Recent Developments
  19. 8.4 Daiichi Sankyo Co Ltd
  20. 8.4.1 Daiichi Sankyo Co Ltd Company Information
  21. 8.4.2 Daiichi Sankyo Co Ltd Business Overview
  22. 8.4.3 Daiichi Sankyo Co Ltd Hepcidin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Daiichi Sankyo Co Ltd Hepcidin Product Portfolio
  24. 8.4.5 Daiichi Sankyo Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hepcidin Value Chain Analysis
  2. 9.1.1 Hepcidin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hepcidin Sales Mode & Process
  6. 9.2 Hepcidin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hepcidin Distributors
  9. 9.2.3 Hepcidin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst